U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Antiviral Agents [Pharmacological Action]

Tree Number(s): D000998

MeSH Unique ID: D000998

  • geldanamycin (Supplementary Concept)
  • costunolide (Supplementary Concept)
  • alovudine (Supplementary Concept)
  • pyrazofurin (Supplementary Concept)
  • merocyanine dye (Supplementary Concept)
  • tromantadine (Supplementary Concept)
  • 5'-guanylylmethylenebisphosphonate (Supplementary Concept)
  • hypericin (Supplementary Concept)
  • kethoxal (Supplementary Concept)
  • moroxydine (Supplementary Concept)
  • palmidrol (Supplementary Concept)
  • avridine (Supplementary Concept)
  • 5-bromouridine (Supplementary Concept)
  • hypoxanthine arabinoside (Supplementary Concept)
  • iodoantipyrine (Supplementary Concept)
  • lapachol (Supplementary Concept)
  • ribavirin-5'-phosphate (Supplementary Concept)
  • selenocystine (Supplementary Concept)
  • surfactin peptide (Supplementary Concept)
  • tetrandrine (Supplementary Concept)
  • ammonium tungsten antimonate hydroxide oxide (Supplementary Concept)
  • thymine arabinoside (Supplementary Concept)
  • 9-(2-hydroxy-3-nonyl)adenine (Supplementary Concept)
  • bifidobacterin (Supplementary Concept)
  • polysaccharide-K (Supplementary Concept)
  • ibacitabine (Supplementary Concept)
  • troclosene (Supplementary Concept)
  • 5-mercapto-2'-deoxyuridine (Supplementary Concept)
  • sparfosic acid (Supplementary Concept)
  • deoxypodophyllotoxin (Supplementary Concept)
  • enocitabine (Supplementary Concept)
  • 9-(2,3-dihydroxypropyl)adenine (Supplementary Concept)
  • amiprilose (Supplementary Concept)
  • alpha-terthienyl (Supplementary Concept)
  • mitonafide (Supplementary Concept)
  • 1-(beta-D-arabinofuranosyl)-5-ethyluracil (Supplementary Concept)
  • brivudine (Supplementary Concept)
  • arildone (Supplementary Concept)
  • interferon tau (Supplementary Concept)
  • viroxime (Supplementary Concept)
  • 9-beta-D-arabinofuranosylguanosine 5'-triphosphate (Supplementary Concept)
  • edoxudin (Supplementary Concept)
  • 2',5'-oligoadenylate (Supplementary Concept)
  • avarol (Supplementary Concept)
  • 5-(aminomethyl)-2'-deoxyuridine (Supplementary Concept)
  • 5-((methylthio)methyl)-2'-deoxyuridine (Supplementary Concept)
  • beta-aspartylhydroxamic acid (Supplementary Concept)
  • acyclovir triphosphate (Supplementary Concept)
  • saikosaponin D (Supplementary Concept)
  • fiacitabine (Supplementary Concept)
  • acyclovir monophosphate (Supplementary Concept)
  • oltipraz (Supplementary Concept)
  • taribavirin (Supplementary Concept)
  • thymidine 5'-diphosphate (Supplementary Concept)
  • N-(guanosin-8-yl)-4-aminobiphenyl (Supplementary Concept)
  • hydroxyguanidine (Supplementary Concept)
  • stallimycin (Supplementary Concept)
  • didemnins (Supplementary Concept)
  • 5-(2-iodovinyl)-2'-deoxyuridine (Supplementary Concept)
  • andrographolide (Supplementary Concept)
  • neplanocin A (Supplementary Concept)
  • pepsinated immunoglobulin G (Supplementary Concept)
  • sorivudine (Supplementary Concept)
  • 1-beta-arabinofuranosyl-5-(2-chlorovinyl)uracil (Supplementary Concept)
  • ursodoxicoltaurine (Supplementary Concept)
  • 5-(2-chlorovinyl)-2'-deoxyuridine (Supplementary Concept)
  • 5-(3,3,3-trifluoro-1-propenyl) 2'-deoxyuridine (Supplementary Concept)
  • N-methyldeoxynojirimycin (Supplementary Concept)
  • clevudine (Supplementary Concept)
  • 2-fluoro-araATP (Supplementary Concept)
  • stepronin (Supplementary Concept)
  • 8-hydroxyacyclovir (Supplementary Concept)
  • 9-carboxymethoxymethylguanine (Supplementary Concept)
  • adenylyl-(3'-5')-virazole (Supplementary Concept)
  • concanamycin A (Supplementary Concept)
  • amonafide (Supplementary Concept)
  • oxymatrine (Supplementary Concept)
  • buciclovir (Supplementary Concept)
  • ribavirin 5'-triphosphate (Supplementary Concept)
  • selenazofurin (Supplementary Concept)
  • heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanine (Supplementary Concept)
  • 2'-O-glycyl acyclovir (Supplementary Concept)
  • 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 (Supplementary Concept)
  • thymidine 5'-O-(1-thiotriphosphate) (Supplementary Concept)
  • desciclovir (Supplementary Concept)
  • vesnarinone (Supplementary Concept)
  • 5-(2-fluorovinyl)-2'-deoxyuridine (Supplementary Concept)
  • 9-(1,3-dihydroxy-2-propoxymethyl)-GMP (Supplementary Concept)
  • N-chlorotaurine (Supplementary Concept)
  • fialuridine (Supplementary Concept)
  • jacalin (Supplementary Concept)
  • 9-((2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl)guanine P-oxide (Supplementary Concept)
  • 5-(2-bromovinyl)-2'-deoxycytidine (Supplementary Concept)
  • 9-((2,3-dihydroxy-1-propoxy)methyl)guanine (Supplementary Concept)
  • disoxaril (Supplementary Concept)
  • tricyclodecane-9-yl-xanthogenate (Supplementary Concept)
  • 5-(2-bromoethyl)-2'-deoxyuridine (Supplementary Concept)
  • 5-(2-chloroethyl)-2'-deoxyuridine (Supplementary Concept)
  • poly(I).poly(c12,U) (Supplementary Concept)
  • 5-(2-bromovinyl)uridine (Supplementary Concept)
  • hypocrellin A (Supplementary Concept)
  • 5-vinyl-1-arabinofuranosyluracil (Supplementary Concept)
  • ajoene (Supplementary Concept)
  • picrosteganol (Supplementary Concept)
  • 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine (Supplementary Concept)
  • 2',3'-dideoxyguanosine (Supplementary Concept)
  • interferon alfacon-1 (Supplementary Concept)
  • oxetanocin (Supplementary Concept)
  • arabinofuranosyl-E-5-iodovinyluracil (Supplementary Concept)
  • 9-(4-hydroxy-3-hydroxymethyl-2-butenyl)guanine (Supplementary Concept)
  • zidovudine triphosphate (Supplementary Concept)
  • adefovir (Supplementary Concept)
  • penciclovir (Supplementary Concept)
  • lexitropsin (Supplementary Concept)
  • 3'-azido-3'-deoxyarabinothymidine (Supplementary Concept)
  • 2'-fluoro-5-ethylarabinosyluracil (Supplementary Concept)
  • 3'-fluoro-2',3'-dideoxyguanosine (Supplementary Concept)
  • BIOLF 143 (Supplementary Concept)
  • 2'-deoxy-2'-methylenecytidine (Supplementary Concept)
  • GLA 60 (Supplementary Concept)
  • pseudohypericin (Supplementary Concept)
  • 9-(5'-deoxy-5'-(methylthio)-xylofuranosyl)adenine (Supplementary Concept)
  • 3'-azido-2',3'-dideoxy-5-methylcytidine (Supplementary Concept)
  • 2'-deoxyadenosine (Supplementary Concept)
  • acemannan (Supplementary Concept)
  • 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (Supplementary Concept)
  • 2-thiothymidine (Supplementary Concept)
  • 2-amino-1,9-dihydro-9-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-6H-purine-6-one (Supplementary Concept)
  • 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (Supplementary Concept)
  • curdlan sulfate (Supplementary Concept)
  • 5'-thioadenosine (Supplementary Concept)
  • 5-propynylarabinofuranosyluracil (Supplementary Concept)
  • 6-methoxypurine arabinoside (Supplementary Concept)
  • Racivir (Supplementary Concept)
  • 2'3'-didehydro-2'3'-dideoxyadenosine (Supplementary Concept)
  • L-697661 (Supplementary Concept)
  • ridostin (Supplementary Concept)
  • 3'-amino-2',3'-dideoxyuridine (Supplementary Concept)
  • 6-chloropurine (Supplementary Concept)
  • 3'-azido-2',3'-dideoxy-5-iodouridine (Supplementary Concept)
  • loviride (Supplementary Concept)
  • silicon phthalocyanine (Supplementary Concept)
  • 8-ethyladenosine (Supplementary Concept)
  • 2'-deoxy-2'-fluoroguanosine (Supplementary Concept)
  • fomivirsen (Supplementary Concept)
  • ganciclovir triphosphate (Supplementary Concept)
  • peginterferon alfa-2a (Supplementary Concept)
  • prostaglandin A1 (Supplementary Concept)
  • adefovir dipivoxil (Supplementary Concept)
  • pleconaril (Supplementary Concept)
  • rupintrivir (Supplementary Concept)
  • maribavir (Supplementary Concept)
  • entecavir (Supplementary Concept)
  • peramivir (Supplementary Concept)
  • peginterferon alfa-2b (Supplementary Concept)
  • pritelivir (Supplementary Concept)
  • favipiravir (Supplementary Concept)
  • stampidine (Supplementary Concept)
  • pradefovir (Supplementary Concept)
  • 8-methoxy-2'-deoxyguanosine (Supplementary Concept)
  • tecovirimat (Supplementary Concept)
  • interferon-lambda protein, mouse (Supplementary Concept)
  • galidesivir (Supplementary Concept)
  • hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine (Supplementary Concept)
  • brincidofovir (Supplementary Concept)
  • smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (Supplementary Concept)
  • docosanol (Supplementary Concept)
  • pentanedioic acid imidazolyl ethanamide (Supplementary Concept)
  • laninamivir (Supplementary Concept)
  • islatravir (Supplementary Concept)
  • grazoprevir (Supplementary Concept)
  • vesatolimod (Supplementary Concept)
  • ledipasvir (Supplementary Concept)
  • letermovir (Supplementary Concept)
  • ledipasvir, sofosbuvir drug combination (Supplementary Concept)
  • velpatasvir (Supplementary Concept)
  • remdesivir (Supplementary Concept)
  • elbasvir-grazoprevir drug combination (Supplementary Concept)
  • sofosbuvir-velpatasvir drug combination (Supplementary Concept)
  • emtricitabine tenofovir alafenamide (Supplementary Concept)
  • pocapavir (Supplementary Concept)
  • ruzasvir (Supplementary Concept)
  • houttuynoid A (Supplementary Concept)
  • PC-786 (Supplementary Concept)
  • JNJ-632 (Supplementary Concept)
  • 3-(1H-indol-3-yl)-2,3-dihydro-4H-furo(3,2-c)chromen-4-one (Supplementary Concept)
  • BMS-986097 (Supplementary Concept)
  • uprifosbuvir (Supplementary Concept)
  • MEDI8852 (Supplementary Concept)
  • radavirsen (Supplementary Concept)
  • REP 2139 (Supplementary Concept)
  • cytosinpeptidemycin (Supplementary Concept)
  • baloxavir (Supplementary Concept)
  • san wu huangqin (Supplementary Concept)
  • 1-adamantyl (5-bromo-2-methoxybenzyl) amine (Supplementary Concept)
  • 4'-cyano-2'-deoxyguanosine (Supplementary Concept)
  • yimitasvir (Supplementary Concept)
  • 3-cyano-4,6-diphenylpyridine (Supplementary Concept)
  • scequinadoline A (Supplementary Concept)
  • seco-A-oleanane-3,4-lactone (Supplementary Concept)
  • odalasvir (Supplementary Concept)
  • adafosbuvir (Supplementary Concept)
  • molnupiravir (Supplementary Concept)
  • GS-441524 triphosphate (Supplementary Concept)
  • ziresovir (Supplementary Concept)
  • GS-441524 (Supplementary Concept)
  • astegolimab (Supplementary Concept)
  • avdoralimab (Supplementary Concept)
  • gimsilumab (Supplementary Concept)
  • remestemcel-l (Supplementary Concept)
  • zansecimab (Supplementary Concept)
  • bamlanivimab (Supplementary Concept)
  • casirivimab and imdevimab drug combination (Supplementary Concept)
  • meplazumab (Supplementary Concept)
  • interferon-alfa-1b (Supplementary Concept)
  • plonmarlimab (Supplementary Concept)
  • deldeprevir (Supplementary Concept)
  • ansuvimab (Supplementary Concept)
  • atoltivimab (Supplementary Concept)
  • maftivimab (Supplementary Concept)
  • odesivimab (Supplementary Concept)
  • atoltivimab, maftivimab, and odesivimab-ebgn drug combination (Supplementary Concept)
  • sotrovimab (Supplementary Concept)
  • gontivimab (Supplementary Concept)
  • pyronaridine tetraphosphate, artesunate drug combination (Supplementary Concept)
  • ALG-097111 (Supplementary Concept)
  • cilgavimab and tixagevimab drug combination (Supplementary Concept)
  • JNJ-56136379 (Supplementary Concept)
  • nirmatrelvir and ritonavir drug combination (Supplementary Concept)
  • ChAd63 Pfs25-IMX313 malaria vaccine (Supplementary Concept)
  • MVA Pfs25-IMX313 malaria vaccine (Supplementary Concept)
  • IMP-1088 (Supplementary Concept)
  • EDP-938 (Supplementary Concept)
  • (+)-4-(3-((1-(4-chlorophenyl)-2-oxo2-(6-(trifluoromethoxy)indolin-1-yl)ethyl)amino)-5-methoxyphenoxy)butanoic acid (Supplementary Concept)
  • nigirpexin E (Supplementary Concept)
  • Acetylcysteine (MeSH Term)
  • Acyclovir (MeSH Term)
  • Amantadine (MeSH Term)
  • Vidarabine Phosphate (MeSH Term)
  • Bromodeoxyuridine (MeSH Term)
  • Cytarabine (MeSH Term)
  • Deoxyglucose (MeSH Term)
  • Ditiocarb (MeSH Term)
  • Filipin (MeSH Term)
  • Idoxuridine (MeSH Term)
  • Interferon Type I (MeSH Term)
  • Interferon-gamma (MeSH Term)
  • Interferons (MeSH Term)
  • Inosine Pranobex (MeSH Term)
  • Methisazone (MeSH Term)
  • Netropsin (MeSH Term)
  • Phosphonoacetic Acid (MeSH Term)
  • Poly A-U (MeSH Term)
  • Poly I-C (MeSH Term)
  • Pyran Copolymer (MeSH Term)
  • Ribavirin (MeSH Term)
  • Rimantadine (MeSH Term)
  • Streptovaricin (MeSH Term)
  • Tenuazonic Acid (MeSH Term)
  • Tilorone (MeSH Term)
  • Trifluridine (MeSH Term)
  • Tunicamycin (MeSH Term)
  • Vidarabine (MeSH Term)
  • Dideoxynucleosides (MeSH Term)
  • Ganciclovir (MeSH Term)
  • Dideoxyadenosine (MeSH Term)
  • Aphidicolin (MeSH Term)
  • Interferon-alpha (MeSH Term)
  • Interferon-beta (MeSH Term)
  • Foscarnet (MeSH Term)
  • 1-Deoxynojirimycin (MeSH Term)
  • Brefeldin A (MeSH Term)
  • Oseltamivir (MeSH Term)
  • Zanamivir (MeSH Term)
  • Interferon beta-1a (MeSH Term)
  • Emtricitabine, Rilpivirine, Tenofovir Drug Combination (MeSH Term)
  • Emtricitabine (MeSH Term)
  • Tenofovir (MeSH Term)
  • Palivizumab (MeSH Term)
  • Sofosbuvir (MeSH Term)
  • Simeprevir (MeSH Term)
  • Interferon alpha-2 (MeSH Term)
  • Artesunate (MeSH Term)
  • Cidofovir (MeSH Term)
  • Valacyclovir (MeSH Term)
  • Roscovitine (MeSH Term)
  • Valganciclovir (MeSH Term)
  • Famciclovir (MeSH Term)
  • Telbivudine (MeSH Term)
  • XZ456 (Supplementary Concept)
  • UC-781 (Supplementary Concept)
  • elvitegravir (Supplementary Concept)
  • efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • UB-421 (Supplementary Concept)
  • XZ462 (Supplementary Concept)
  • cabotegravir, rilpivirine drug combination (Supplementary Concept)
  • lobucavir (Supplementary Concept)
  • aminomethyltrioxsalen (Supplementary Concept)
  • virion host shutoff protein, Simplexvirus (Supplementary Concept)
  • troxacitabine (Supplementary Concept)
  • TSAO-T (Supplementary Concept)
  • calanolide A (Supplementary Concept)
  • plerixafor (Supplementary Concept)
  • recombinant soluble CD4 (Supplementary Concept)
  • viscum album peptide (Supplementary Concept)
  • kynostatin 272 (Supplementary Concept)
  • vMIP-II (Supplementary Concept)
  • lamivudine, zidovudine drug combination (Supplementary Concept)
  • murabutide (Supplementary Concept)
  • abacavir, dolutegravir, and lamivudine drug combination (Supplementary Concept)
  • 3'-deoxycytidine (Supplementary Concept)
  • ibalizumab (Supplementary Concept)
  • Dapivirine (Supplementary Concept)
  • azodicarbonamide (Supplementary Concept)
  • BMS-955176 (Supplementary Concept)
  • GEM91 (Supplementary Concept)
  • aldesleukin (Supplementary Concept)
  • cosalane (Supplementary Concept)
  • fostemsavir (Supplementary Concept)
  • amprenavir (Supplementary Concept)
  • dexelvucitabine (Supplementary Concept)
  • fosamprenavir (Supplementary Concept)
  • capravirine (Supplementary Concept)
  • carbovir (Supplementary Concept)
  • pradimicin A (Supplementary Concept)
  • miglustat (Supplementary Concept)
  • elsulfavirine (Supplementary Concept)
  • GSK-2838232 (Supplementary Concept)
  • dolutegravir, rilpivirine drug combination (Supplementary Concept)
  • cobicistat mixture with darunavir (Supplementary Concept)
  • stavudine, lamivudine, nevirapine drug combination (Supplementary Concept)
  • GS-9131 (Supplementary Concept)
  • abacavir (Supplementary Concept)
  • tipranavir (Supplementary Concept)
  • R-82913 (Supplementary Concept)
  • N-gamma-glutamylcysteine ethyl ester (Supplementary Concept)
  • XZ460 (Supplementary Concept)
  • ubenimex (Supplementary Concept)
  • UK 457,758 (Supplementary Concept)
  • cenicriviroc (Supplementary Concept)
  • TAK 779 (Supplementary Concept)
  • AD 101 (Supplementary Concept)
  • PF 232798 (Supplementary Concept)
  • CMPD 167 (Supplementary Concept)
  • N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide (Supplementary Concept)
  • N-(3-isopropyl-3-((4-(4-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)carbonyl)cyclopentyl)-3-methoxytetrahydro-2H-pyran-4-amine (Supplementary Concept)
  • GSK 163929 (Supplementary Concept)
  • 4-(4-((1-butyl-3-(cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenoxy)benzoic acid (Supplementary Concept)
  • nifeviroc (Supplementary Concept)
  • TD-0680 (Supplementary Concept)
  • RO-5657 (Supplementary Concept)
  • Ancriviroc (Supplementary Concept)
  • (4,6-dimethyl-1-oxypyrimidin-5-yl)(4-diphenylamino-4'-methyl-(1,4')bipiperidinyl-1'-yl)methanone (Supplementary Concept)
  • RANTES, N(alpha)-(n-nonanoyl)-desSer(1)-(thioproline(2),cyclohexylglycine(3))- (Supplementary Concept)
  • 1-(3-aminopropyl) piperazine-4-aminoamide (Supplementary Concept)
  • BMS-488043 (Supplementary Concept)
  • leronlimab (Supplementary Concept)
  • aplaviroc (Supplementary Concept)
  • phenyl-1H-pyrrole-carboxamide (Supplementary Concept)
  • 3,5-dicaffeoylquinic acid (Supplementary Concept)
  • chicoric acid (Supplementary Concept)
  • aspochalasin L (Supplementary Concept)
  • dolutegravir (Supplementary Concept)
  • EBR28 peptide (Supplementary Concept)
  • BMS-707035 (Supplementary Concept)
  • 7-(3,4-dichlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
  • 7-(4-chlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
  • cabotegravir (Supplementary Concept)
  • MUT-A compound (Supplementary Concept)
  • INRAT10b (Supplementary Concept)
  • DMP 323 (Supplementary Concept)
  • Abbott 77003 (Supplementary Concept)
  • tetrahydrofuranylcarbamatemonopyrrolinone (Supplementary Concept)
  • hinnuliquinone (Supplementary Concept)
  • N-(2''-hydroxy-2''-(4-hydroxy-16-oxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-15-azabenzocyclotetradecen-14-yl)ethyl)-N-isobutyl-4-methoxybenzenesulfonamide (Supplementary Concept)
  • atevirdine (Supplementary Concept)
  • 6-(1-(2,6-difluorophenyl)ethyl)-2-(dimethylamino)-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
  • sulfoquinovosyl diglyceride (Supplementary Concept)
  • emivirine (Supplementary Concept)
  • beta-lapachone (Supplementary Concept)
  • efavirenz (Supplementary Concept)
  • 2-cyclopentylthio-6-(1-(2,6-difluorophenyl)ethyl)-3,4-dihydro-5-methylpyrimidin-4(3H)-one (Supplementary Concept)
  • etravirine (Supplementary Concept)
  • ammonium trichloro(dioxoethylene-O,O'-)tellurate (Supplementary Concept)
  • ulonivirine (Supplementary Concept)
  • nirmatrelvir (Supplementary Concept)
  • Zidovudine (MeSH Term)
  • Trichosanthin (MeSH Term)
  • Zalcitabine (MeSH Term)
  • Didanosine (MeSH Term)
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Rilpivirine (MeSH Term)
  • Raltegravir Potassium (MeSH Term)
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Cobicistat (MeSH Term)
  • Stavudine (MeSH Term)
  • Lamivudine (MeSH Term)
  • Nevirapine (MeSH Term)
  • Delavirdine (MeSH Term)
  • Maraviroc (MeSH Term)
  • Enfuvirtide (MeSH Term)
  • Atazanavir Sulfate (MeSH Term)
  • Darunavir (MeSH Term)
  • Saquinavir (MeSH Term)
  • Ritonavir (MeSH Term)
  • Indinavir (MeSH Term)
  • Nelfinavir (MeSH Term)
  • Lopinavir (MeSH Term)

Supplemental Content

Loading ...